Amended Complaint Filed Over Ditropan
Less than three weeks after a federal judge threw out an antitrust class action complaint against the maker of the bladder drug Ditropan XL, the plaintiffs filed an amended complaint Tuesday...To view the full article, register now.
Already a subscriber? Click here to view full article